The drug-buying agency Pharmac is refusing to be rushed into funding a hotly debated new drug for advanced melanoma. Pharmac's chief executive, Steffan Crausaz talks to Karen Brown.
Recent stories from Morning Report
Get the RNZ app
for easy access to all your favourite programmes
